Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment
Overview
Authors
Affiliations
Purpose: To analyze the efficacy of tocilizumab in uveitic macular edema (ME) resistant to various immunomodulatory drugs.
Methods: Patients received tocilizumab every 4 weeks intravenously. Central foveal thickness (CFT) was assessed by optical coherence tomography (OCT).
Results: Five patients (8 eyes) who were ineffectively pretreated with systemic prednisolone, at least one immunosuppressive drug, and at least one biologic drug for uveitic macular edema were included in the study. At 3 months, a response of ME (≥25% reduction in CFT) was observed in 6 eyes (75.0%) of 5 patients. During follow-up, complete resolution of ME was achieved in 5 eyes (62.5%) of 4 patients. Improvement of BCVA was observed in 3 eyes of 3 patients, and stabilization in 3 eyes of 3 patients. Tocilizumab was well tolerated, and no severe side effects occurred.
Conclusions: Treatment with tocilizumab can be considered in chronic uveitic macular edema even if previous immunomodulatory therapy has failed.
Recurrent uveitic macular edema managed with intravitreal faricimab injection.
Yavari N, Feky D, Anover F, Nguyen K, Mobasserian A, Nguyen Q J Ophthalmic Inflamm Infect. 2025; 15(1):25.
PMID: 40080237 PMC: 11906930. DOI: 10.1186/s12348-025-00478-6.
Tocilizumab for cystoid macular edema secondary to retinitis pigmentosa.
Abramowicz S, Kamgang Semeu P, Nubourgh I, Postelmans L, Willermain F J Ophthalmic Inflamm Infect. 2024; 14(1):47.
PMID: 39349884 PMC: 11442707. DOI: 10.1186/s12348-024-00430-0.
Use of immunomodulators in non-infectious uveitis: lights and shadows.
Bernal-Morales C, Ramanan A, Pavesio C Eye (Lond). 2024; 38(17):3231-3242.
PMID: 39160332 PMC: 11584895. DOI: 10.1038/s41433-024-03294-9.
Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond.
Chauhan K, Tyagi M Front Ophthalmol (Lausanne). 2024; 4:1412930.
PMID: 39157460 PMC: 11327136. DOI: 10.3389/fopht.2024.1412930.
An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis.
Esteban-Ortega M, Steiner M, Andreu-Vazquez C, Thuissard-Vasallo I, Diaz-Rato A, Munoz-Fernandez S J Clin Med. 2024; 13(5).
PMID: 38592203 PMC: 10933845. DOI: 10.3390/jcm13051402.